Toward a potential paradigm shift for the clinical care of diabetic patients requiring perineural analgesia: strategies for using the diabetic rodent model.
Williams
Brian A
BA
D000322:Adrenergic Agonists / Q000008:administration & dosage; D000577:Amides / Q000008:administration & dosage; D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000633:toxicity; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007267:Injections; D008012:Lidocaine / Q000008:administration & dosage; D009043:Motor Activity / Q000187:drug effects; D009407:Nerve Block / Q000009:adverse effects; D009410:Nerve Degeneration / Q000139:chemically induced; D051381:Rats; D018570:Risk Assessment; D000077212:Ropivacaine; D012584:Sciatic Nerve / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D012677:Sensation / Q000187:drug effects; D013997:Time Factors
D000322:Adrenergic Agonists; D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine; D008012:Lidocaine